
IndraLab
Statements
reach
"In IM-resistant CML, pharmacological inhibition of ubiquitin-specific peptidase 47 (USP47) with P22077 reduces the percentage of CD34 CD38 cells in secondary BM transplantation and inhibits colony-forming activity of CD34 cells from IM-resistant CML patients while sparing normal CD34 cells [234]."